5.4 Patient Assessment, Self-Care & Point-of-Care Testing
Key Takeaways
Person-Centered Assessment explicitly includes medication and allergy reconciliation, health screening, OTC and dietary-supplement self-care triage, and use of administration devices and self-monitoring tools.
Medication reconciliation compares the patient's actual medication list against orders at every transition of care to catch omissions, duplications, and dosing errors.
OTC self-care triage means recognizing red-flag symptoms that exceed self-treatment and require referral rather than recommending a nonprescription product.
Pharmacists interpret point-of-care and self-monitoring data (blood pressure, blood glucose/HbA1c, INR, lipid panels) and counsel on correct device technique.
Many dietary supplements and herbal products have clinically important interactions (e.g., St. John's wort induces CYP3A4; high-dose vitamin K antagonizes warfarin).
Assessment as the Front Door of Person-Centered Care
The Person-Centered Assessment and Treatment Planning domain (40%) is not only disease-state therapeutics; it explicitly includes assessment activities — reconciliation, screening, self-care triage, supplement evaluation, and interpreting self-monitoring data. These are recurring item types where the best answer is to gather or verify information, or refer, rather than immediately recommend a drug.
Medication and Allergy Reconciliation
Medication reconciliation is the process of creating the most accurate possible list of everything a patient is taking — prescriptions, OTCs, supplements, doses, routes, frequencies — and comparing it against what is ordered at each transition of care (admission, transfer, discharge). It catches:
- Omissions — a chronic medication left off after hospitalization
- Duplications — two agents in the same class
- Dose/frequency discrepancies and route errors
- Allergy gaps — distinguishing a true allergy (e.g., hives, anaphylaxis) from an intolerance (e.g., nausea), which changes whether an entire drug class is truly off-limits
Accurate allergy documentation prevents both unsafe exposure and unnecessary avoidance of first-line therapy.
Interpreting Common Labs and Reference Ranges
Person-centered assessment requires reading basic labs to judge therapy appropriateness, dosing, and monitoring. Know the direction a value should move and what is actionable.
| Lab | Approximate adult reference | Pharmacy relevance |
|---|---|---|
| Serum potassium | 3.5-5.0 mEq/L | High with ACEi/ARB/MRA/K-supplements; low with loop/thiazide diuretics |
| Serum creatinine / eGFR | SCr ~0.6-1.2 mg/dL | Drives renal dose adjustment (Cockcroft-Gault) and drug avoidance |
| Potassium and sodium | Na 135-145 mEq/L | Hyponatremia with thiazides, SSRIs, carbamazepine |
| INR | ~2-3 for most warfarin indications | High INR + bleeding is urgent; supratherapeutic needs dose hold/vitamin K |
| HbA1c | Goal often <7% (individualized) | Reflects ~3-month glucose; guides diabetes intensification |
| ANC | Neutropenia <1,500/microL | Drives clozapine, chemotherapy, and infection monitoring |
| Hepatic enzymes (ALT/AST) | Roughly up to ~40 U/L | Rising values flag hepatotoxic drugs (statins, isoniazid, acetaminophen) |
Exam cue: A lab value alone is rarely the answer; the question is usually what to do with it - hold a drug, adjust a dose, refer, or monitor.
Health Screening and Physical-Assessment Basics
Pharmacists increasingly screen and triage. The exam expects recognition of normal versus actionable findings and the appropriate response.
| Parameter | Actionable concept |
|---|---|
| Blood pressure | Confirm elevated readings; recognize a hypertensive emergency (acute target-organ damage) needing urgent referral |
| Blood glucose / HbA1c | HbA1c reflects ~3-month average control; recognize hypo- and hyperglycemia symptoms |
| INR | Therapeutic range for most warfarin indications is about 2-3; a high INR with bleeding is urgent |
| Lipid panel | Interpret in the context of overall ASCVD risk, not LDL-C alone |
| Temperature / signs of infection | Fever with neutropenia or sepsis features needs emergency care |
The pharmacist's role is to screen, counsel, and refer, working within scope and collaborative agreements rather than diagnosing independently.
OTC Self-Care Triage and Referral Red Flags
Nonprescription product recommendations are a high-yield, frequently tested skill. Structured triage (such as the QuEST/SCHOLAR approach — explore Symptoms, Characteristics, History, Onset, Location, Aggravating/Remitting factors) determines whether self-care is appropriate or referral is required.
Common red flags that exceed self-treatment and warrant referral:
- Symptoms lasting beyond the OTC label's stated duration, or worsening despite therapy
- High fever, severe or escalating pain, or signs of a serious infection
- Symptoms in high-risk groups (young infants, pregnancy, significant comorbidity, immunosuppression)
- "Alarm" features: blood in stool/vomit/urine, chest pain, shortness of breath, neurologic changes, unintended weight loss, dehydration in the very young or old
Exam cue: When a self-care vignette contains a red flag (e.g., a 4-week cough with weight loss, or diarrhea with blood and high fever), the correct answer is refer to a provider, not pick an OTC product.
Dietary Supplements and Herbal Interactions
Supplements are part of the medication list and carry real interactions the NAPLEX tests:
| Supplement | Key concern |
|---|---|
| St. John's wort | Potent CYP3A4 (and P-glycoprotein) inducer; lowers levels of many drugs (oral contraceptives, certain immunosuppressants, some HIV/oncology agents) and adds serotonergic risk |
| Vitamin K-rich products / high-dose vitamin K | Antagonize warfarin; emphasize consistency, not strict avoidance |
| Ginkgo, garlic, high-dose fish oil, vitamin E | Additive bleeding risk with antiplatelets/anticoagulants |
| Potassium-containing salt substitutes | Additive hyperkalemia with ACEi/ARB/MRA |
| Calcium, iron, magnesium, antacids | Chelate and reduce absorption of levothyroxine, fluoroquinolones, tetracyclines |
Counsel patients that "natural" does not mean inert or safe, and that supplements are not held to the same premarket standard as approved drugs.
Point-of-Care Testing and Self-Monitoring Devices
Pharmacists interpret point-of-care (POC) results and teach patients to use self-monitoring devices correctly — a named competency (administration devices and self-monitoring tools).
- Home blood pressure monitors: correct cuff size and arm position, rest before measuring, multiple readings averaged.
- Blood glucose meters and continuous glucose monitors (CGMs): technique, calibration where applicable, and recognizing readings that need action.
- Inhalers, spacers, and peak-flow meters: device technique directly affects control (see pulmonary section).
- Injectable device counseling: insulin pens, GLP-1 agonist pens, epinephrine autoinjectors — site rotation, priming, and storage.
- POC tests (rapid strep, influenza, INR, A1c, lipid, COVID-19) support screening and therapy decisions within scope.
Counseling pearl: Apparent "treatment failure" is frequently a device-technique problem. Before escalating therapy, verify the patient is using the device correctly with a teach-back or return demonstration.
A 25-year-old otherwise healthy patient asks for an OTC cough product. On questioning, the cough has lasted 5 weeks, with night sweats and a 10-pound unintentional weight loss. What is the most appropriate action?
Recommend a dextromethorphan-containing OTC product
Refer the patient to a provider because the duration and systemic red flags exceed self-care
Recommend an OTC antihistamine and reassess in 2 months
Tell the patient nothing can be done without a prescription cough syrup
A patient stabilized on warfarin begins taking St. John's wort for low mood. What is the most likely consequence the pharmacist should anticipate?
St. John's wort has no effect on warfarin
St. John's wort induces metabolizing enzymes and can lower warfarin's effect, reducing the INR and increasing clot risk
St. John's wort directly increases the INR and bleeding risk
St. John's wort permanently inactivates warfarin
During medication reconciliation at hospital discharge, a pharmacist notes the patient's home metoprolol was inadvertently omitted from the discharge orders. What does this finding best represent, and what is the appropriate step?
A therapeutic duplication; stop one beta-blocker
An omission discrepancy; clarify with the prescriber to restart the indicated home medication
A normal expected change requiring no action
An allergy that contraindicates the drug
A patient on lisinopril and spironolactone for heart failure has a new serum potassium of 6.1 mEq/L. What does the pharmacist do with this value?
Nothing; this potassium is within the normal range
Recognize hyperkalemia driven by the ACE inhibitor plus the MRA and act (hold/adjust therapy and alert the prescriber)
Recommend a potassium supplement to keep the level stable
Add a thiazide to raise potassium
Sections you finish are checked off in the contents.